Skip to main content
. 2024 Mar 9;47(9):2249–2260. doi: 10.1007/s40618-024-02323-4

Fig. 2.

Fig. 2

Secretion of the adipokines that are not affected by gender-affirming therapy. Adipokines were measured by Luminex multiplexing assay in TW (n = 6) and TM (n = 8). Measurements were performed before initiated treatment (T00), 1 month after initiated gonadal down-regulation (T0), 3 months (T3) and 11 months (T11) after gender-affirming hormonal treatment was started. The secretion is expressed as pg/ml. Differences between the groups were calculated using one-way ANOVA with multiple comparisons